CBT Stock Recent News
CBT LATEST HEADLINES
Cabot (CBT) reported earnings 30 days ago. What's next for the stock?
Cabot Corporation outperforms its sector, offering growth and income opportunities, making it a strong buy candidate. CBT's two segments, Reinforcement Materials and Performance Chemicals, show impressive EBIT margin growth and revenue recovery. CBT's growing EPS, strong cash flow, and aggressive share buyback program enhance its financial resilience and shareholder value.
Cabot Corporation (NYSE:CBT ) Q1 2025 Earnings Conference Call January 30, 2025 8:00 AM ET Company Participants Sean Keohane - President & CEO Erica McLaughlin - EVP & CFO Steve Delahunt - VP, Treasurer & IR Conference Call Participants Chris Perrella - UBS John Roberts - Mizuho Group David Begleiter - Deutsche Bank Kevin Estok - Jefferies Lydia Huang - J.P. Morgan Operator Good day.
Cabot misses Q1 earnings and revenue estimates but demonstrates better results in EBIT and adjusted EPS metrics.
Cabot (CBT) came out with quarterly earnings of $1.76 per share, missing the Zacks Consensus Estimate of $1.80 per share. This compares to earnings of $1.56 per share a year ago.
BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) today announced results for its first quarter of fiscal year 2025. Key Highlights Diluted EPS of $1.67 and Adjusted EPS of $1.76 which represents a 13% increase in Adjusted EPS compared to the same quarter in the prior year Reinforcement Materials segment EBIT of $130 million; up 1% compared to the same quarter in the prior year Performance Chemicals segment EBIT of $45 million; up 32% compared to the same quarter in the prior year Cash Flows from Operations of $124 million in the first fiscal quarter supported the return of $66 million of cash to shareholders in the quarter Hosted Investor Day highlighting growth strategy and 3-Year financial targets (In millions, except per share amounts) Three Months Ended 12/31/24 12/31/23 Net sales and other operating revenues $ 955 $ 958 Net income (loss) attributable to Cabot Corporation $ 93 $ 50 Net earnings (loss) per share attributable to
Cabot Corporation had a recent 25% drop and bearish MACD crossover, signaling potential technical weakness. The Reinforcement Materials segment continues to drive growth, but recent EPS and revenue revisions indicate challenges ahead. Fiscal 2024 revenue growth was flat, contrasting with a 5-year average of 4.59%, raising concerns about sustaining double-digit EPS growth.
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BOSTON--(BUSINESS WIRE)--On Friday, January 10, 2025, the Board of Directors of Cabot Corporation (NYSE: CBT) declared a quarterly dividend of $0.43 per share on all outstanding shares of the Corporation's common stock. The dividend is payable on March 14, 2025, to stockholders of record at the close of business on February 28, 2025. About Cabot Corporation Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The.
BOSTON--(BUSINESS WIRE)--Cabot Corporation to Announce First Quarter 2025 Operating Results.